MAPT and Alzheimer disease: Overall, this work leveraged expertise in tauopathies to better understand the nature of tau in AD and CTE, and to determine if unique expression patterns exist that might aid in neuropathological assessment, act as novel biomarkers, or provide insight into possible therapeutic targets.